Drug Profile
ONO 4232
Alternative Names: ONO-4232Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Heart failure therapies
- Mechanism of Action Prostaglandin E EP4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute heart failure
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Acute-heart-failure in USA (Injection)
- 30 Sep 2013 Phase-I clinical trials in Acute heart failure in USA (unspecified route)